You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 8, 2024

Litigation Details for Genentech, Inc. v. Amgen Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Genentech, Inc. v. Amgen Inc. (D. Del. 2017)

Docket	⤷ Sign Up	Date Filed	2017-10-06
Court	District Court, D. Delaware	Date Terminated	2020-07-07
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	Plaintiff	Referred To	Sherry R. Fallon
Parties	AMGEN INC.
Patents	7,323,553; 7,622,115; 7,807,799; 8,512,983; 9,441,035; 9,714,293; 9,795,672
Attorneys	Steven W. Lee
Firms	Proskauer Rose LLP
Link to Docket	External link to docket

Biologic Drugs cited in Genentech, Inc. v. Amgen Inc.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for Genentech, Inc. v. Amgen Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2018-10-30	200	Redacted Document	claims from six of those patents. As to the other two, U.S. Pat. 8,512,983 (“Gawlitzek”) and U.S. Pat… 10:05:20 9 territory of patent law or patent land. It shouldn't have …2018, for Plaintiffs to “reduce the number of patents” from the twenty-six asserted to “no more than …constitutional objection to the compelled reduction of patents and claims, see In re Katz Interactive Call Processing…did not want to reduce the patents to eight on the schedule that we were given, but	External link to document
2019-06-17	401	Memorandum Opinion	appear in the following patents: U.S. Patent Nos. 8,512,983 ("the '983 patent"); 9,441,035 …general, however, the '983 patent, '035 patent, and '869 patent relate to various aspects of…326, 381, 476. The '879 patent, '901 patent, and '269 patent disclose humanized and variant…9,441,035 ("the '035 patent"); 8,574,869 ("the '869 patent"); 6,884,879 ("…quot;the '879 patent"); 7,169,901 ("the '901 patent"); and 7,060,269 ("the	External link to document
2019-06-20	407	Order	opinion letters concerning U.S. Patent Nos. 8,574,869 (Kao), 8,512,983 (Gawlitzek), 9,441,035 (Carvalhal…concerning infringement and validity of those patents. The waiver extends to communications pre-dating…Request Nos. 145-150, 152, 155, and 157, where the Patents-in-Suit are defined to be the Kao, Gawlitzek, … on a Pellian Carvalhal, and Fyfe patents. It shall provide these responses and documents wathin-severr… 2017 7 July 2020 1:17-cv-01407 830 Patent Plaintiff District Court, D. Delaware	External link to document
2017-12-12	43	Redacted Document	herein. 182. United States Patent No. 7,622,115 (“the ’115patent”) (Exhibit N hereto), was… 20, 2008 Baca EX N -- 7,622,115 Nov. 24, 2009 … of ABP 215. The patents-in-suit (“the Asserted Patents”) are: US Patent No. …licensee of these patents with the sole right to enforce these patents pursuant to a Patent Licensing Agreement…bevacizumab has been recognized by the Patent Office with dozens of patents covering the antibody itself, methods	External link to document
2019-08-20	480	Stipulation	Regarding Judgment of Non-Infringement of U.S. Patent No. 9,441,035 by City of Hope, Genentech, Inc.. (Silver… 2017 7 July 2020 1:17-cv-01407 830 Patent Plaintiff District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.